Long-term administration of highly purified eicosapentaenoic acid ethyl ester prevents diabetes and abnormalities of blood coagulation in male WBN/Kob rats

Metabolism: Clinical and Experimental

Volumn 49, Issue 7, 2000, Pages 912-919

  Nobukata, Hidefumi ^a   Ishikawa, Tsutomu ^a   Obata, Masaomi ^a   Shibutani, Yasunori ^a  

^a Research Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; CHOLESTEROL; COLLAGEN; FIBRINOGEN; GLUCOSE; ICOSAPENTAENOIC ACID ETHYL ESTER; INSULIN; PHOSPHOLIPID; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; PROTHROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; FIBRINOLYSIS; GLUCOSE INTOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; LONG TERM CARE; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RAT; THROMBOCYTE AGGREGATION;

EID: 0034235639     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2000.6739     Document Type: Article

References (17)

1. 1. Sato M, Katsuki Y, Fukuhara K, et al: Effects of highly purified ethyl all-cis-5,8,11,14, 17-icosapentaenoate (EPA-E) on rabbit platelets. Biol Pharm Bull 16:362-367, 1993
2. 2. Mizuguchi K, Yano T, Ishibashi M, et al: Ethyl all-cis-5,8,11,14,17-icosapentaenoate modifies the biochemical properties of rat very low-density lipoprotein. Eur J Pharmacol 235:221-227, 1993
3. 3. Mizuguchi K, Yano T, Tanaka Y, et al: Mechanism of the lipid-lowering effect of ethyl all-cis-5, 8, 11, 14, 17-icosapentaenoate. Eur J Pharmacol 231:121-127, 1993
4. 4. Mizuguchi K, Yano T, Kojima M, et al: Hypolipidemic effect of ethyl all-cis-5, 8, 11, 14, 17-icosapentaenoate (EPA-E) in rats. Jpn J Pharmacol 59:307-312, 1992
5. 5. Mori Y, Murakawa Y, Katoh S, et al: Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus. Metabolism 46:1458-1464, 1997
6. 6. Mori Y, Murakawa Y, Yokoyama J, et al: Effect of highly purified eicosapentaenoic acid ethyl ester on insulin resistance and hypertension in Dahl salt-sensitive rats. Metabolism 48:1089-1095, 1999
7. 2+ channel blocker on insulin resistance in Dahl-S rats. Jpn Pharmacol Ther 27:63-73, 1999
8. 8. Tsuchitani M, Saegusa T, Narama I, et al: A new diabetic strain of rat (WBN/Kob). Lab Anim 19:200-207, 1985
9. 9. Nobukata H, Ishikawa T, Obata M, et al: Age-related changes in coagulation, fibrinolysis, and platelet aggregation in male WBN/Kob rats. Thromb Res (in press)
10. 10. Kergoat M, Portha B: In vivo hepatic and peripheral insulin sensitivity in rats with non-insulin-dependent diabetes induced by streptozotocin: Assessment with the insulin-glucose clamp technique. Diabetes 34:1120-1126, 1985
11. 11. Hochlberg Y, Tamhane AC: Multiple Comparison Procedures. New York, NY, Wiley, 1987, pp 134-160
12. 12. Terano T, Salmon JA, Higgs GA, et al: Eicosapentaenoic acid as a modulator of inflammation. Effect on prostaglandin and leukotriene synthesis. Biochem Pharmacol 35:779-785, 1986
13. 13. Terano T, Salmon JA, Moncada S: Antiinflammatory effects of eicosapentaenoic acid: Relevance to icosanoid formation. Adv Prostaglandin Thromboxane Leukot Res 15:253-255, 1985
14. 14. Terano T, Salmon JA, Moncada S: Effect of orally administered eicosapentaenoic acid (EPA) on the formation of leukotriene B4 and leukotriene B5 by rat leukocytes. Biochem Pharmacol 33:3071-3076, 1984
15. 15. Terano T, Hirai A, Shiina T, et al: Mechanism of anti-proliferative action of eicosapentaenoic acid (EPA-E) in vascular cell growth: Its effect on signal transduction system. Adv Exp Med Biol 407:399-404, 1997
16. 16. Terano T, Shiina T, Tamura Y: Eicosapentaenoic acid suppressed the proliferation of vascular smooth cells through modulation of various steps of growth signals. Lipids 31:301-304, 1996
17. 17. Shiina T, Terano T, Saito J, et al: Eicosapentaenoic acid and docosahexaenoic acid suppress the proliferation of vascular smooth muscle cells. Atherosclerosis 104:95-103, 1993